系统性蛋白质组分析区分原发性肾小球疾病亚型
该研究对5416种血浆蛋白进行Olink Explore HT检测,在发现队列(n=147)和外部验证队列(n=85)中构建弹性净回归机器学习模型。模型对微小病变、膜性肾病和IgA肾病区分AUC>0.8,但局灶节段性肾小球硬化识别率仅21%。
要点
- 血浆蛋白质组特征可区分原发性肾小球疾病亚型,独立于eGFR或蛋白尿水平。
- 机器学习模型对微小病变、膜性肾病和IgA肾病区分AUC>0.8。
- 模型正确识别93%微小病变和63%IgA肾病病例,但仅21%局灶节段性肾小球硬化病例。
核心结论
- 原发性肾小球疾病存在独特的系统性蛋白质组特征,疾病亚型是蛋白质组变异的主要决定因素之一。
- 机器学习模型对微小病变、膜性肾病和IgA肾病具有稳健的区分性能,支持基于蛋白质组的分类潜力。
研究设计与样本
- 研究通过Olink Explore HT对5416种血浆蛋白进行大规模系统性蛋白质组分析,发现队列n=147,外部验证队列n=85,均为韩国参与者(平均年龄41±13岁,46%女性)。
- 研究人群包括局灶节段性肾小球硬化、IgA肾病、微小病变和膜性肾病四种亚型患者及健康对照,采用弹性净正则化逻辑回归机器学习模型进行分类。
主要发现
- 血浆蛋白质组谱在疾病亚型间存在明显差异,是独立于eGFR或蛋白尿水平的重要数据变异来源。
- 机器学习模型在发现和验证队列中区分微小病变、膜性肾病和IgA肾病的AUC均>0.8。
- 模型在无临床信息情况下正确识别93%的微小病变病例(14/15)和63%的IgA肾病病例(20/32),但仅正确分类21%的局灶节段性肾小球硬化病例(3/14)。
- 关键蛋白功能分析揭示了不同生物学通路,如微小病变中的止血通路。
关键数值与推荐
- 模型区分微小病变、膜性肾病和IgA肾病的AUC>0.8。
- 模型正确识别93%微小病变病例(14/15)、63%IgA肾病病例(20/32)和21%局灶节段性肾小球硬化病例(3/14)。
临床怎么用
- 血浆蛋白质组联合机器学习模型有望作为非侵入性工具辅助区分原发性肾小球疾病亚型,尤其对微小病变、膜性肾病和IgA肾病区分效能较好。
- 对局灶节段性肾小球硬化的识别效能有限,临床应用中需谨慎解读该亚型的模型输出。
局限性
- 局灶节段性肾小球硬化的分类性能有限,仅21%病例被正确分类。
- 研究人群为韩国参与者,外部验证队列样本量较小(n=85),结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: Plasma proteome profiling identified distinct signatures across biopsy-proven primary glomerular disease subtypes. An elastic net model using 93 proteins classified primary glomerular disease subtypes and controls, with external validation. Integrating proteomics with machine learning yields biologically interpretable insights in primary glomerular diseases. BACKGROUND: Primary GN is a heterogeneous group of kidney disorders where understanding of their pathophysiology remains incomplete. Despite the diagnostic potential of high-throughput proteomics, constrained proteomic depth and a reliance on binary comparisons have left the feasibility of using systemic signatures to differentiate multiple GN subtypes largely unexplored. METHODS: To identify protein signatures that noninvasively differentiate major primary glomerular disease subtypes and provide mechanistic insights, we performed large-scale systemic proteome profiling of 5416 plasma proteins via Olink Explore HT in a discovery cohort ( n =147) and an external validation cohort ( n =85) of Korean participants (mean age, 41±13 years; 46% female). The study population included patients with four GN subtypes-focal segmental glomerulosclerosis, IgA nephropathy, minimal change disease, and membranous nephropathy-alongside healthy controls. We developed a machine learning (ML) model using logistic regression with elastic net regularization to classify disease groups based on proteomic profiles and evaluated its performance in the independent validation cohort. RESULTS: Plasma proteome profiles were distinct among disease subtypes, emerging as a significant source of data variation independent of conventional markers such as eGFR or proteinuria levels. The ML model performed robustly in both the discovery and validation cohorts, achieving an area under the receiver operating characteristic curve >0.8 for differentiating minimal change disease, membranous nephropathy, and IgA nephropathy. The model, even without clinical information, correctly identified 93% of minimal change disease cases (14 of 15) and 63% of IgA nephropathy cases (20 of 32), but its performance was limited for focal segmental glomerulosclerosis, with only 21% of cases (three of 14) correctly classified. Functional analysis of key proteins highlighted distinct biologic pathways, such as hemostasis in minimal change disease. CONCLUSIONS: We identified distinct systemic proteome signatures for primary glomerular diseases, where disease subtype served as a major determinant of proteomic variance alongside conventional clinical markers. ML models demonstrated robust discriminatory performance for minimal change disease, membranous nephropathy, and IgA nephropathy, underscoring the potential for proteome-based classification.
引用
- Oh JI, Jeong K, Koh JH, et al. Systemic Proteome Profiling to Differentiate Primary Glomerular Diseases. J Am Soc Nephrol. 2026. PMID: 41779447. doi:10.1681/ASN.0000001054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。